View in EDS

Discovery and characterisation of quinazolines and 8-Azaquinazolines as NLRP3 agonists with oral bioavailability in mice.

Saved in:
Bibliographic Details
Title: Discovery and characterisation of quinazolines and 8-Azaquinazolines as NLRP3 agonists with oral bioavailability in mice.
Authors: O' Donovan DH; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom. Electronic address: daniel.odonovan1@astrazeneca.com., Baker D; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Ciotta G; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Degorce SL; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Demanze S; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Dockerill M; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Escudero-Ibarz L; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Ireland L; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Mao Y; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Packer MJ; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Robinson J; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Scarfe G; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Tang H; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom., Valge-Archer V; Oncology R&D and Discovery Sciences, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, United Kingdom.
Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2023 Nov 15; Vol. 96, pp. 129518. Date of Electronic Publication: 2023 Oct 12.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1464-3405
DOI:10.1016/j.bmcl.2023.129518